GAM
Griffin Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Sell |
6,408
-1,609
| -20% | -$716K | 0.34% | 81 |
|
|
2025
Q1 | $3.89M | Sell |
8,017
-115
| -1% | -$55.8K | 0.48% | 59 |
|
|
2024
Q4 | $3.27M | Sell |
8,132
-581
| -7% | -$234K | 0.38% | 67 |
|
|
2024
Q3 | $4.05M | Buy |
8,713
+15
| +0.2% | +$6.98K | 0.45% | 61 |
|
|
2024
Q2 | $4.08M | Sell |
8,698
-105
| -1% | -$49.2K | 0.47% | 57 |
|
|
2024
Q1 | $3.68M | Sell |
8,803
-157
| -2% | -$65.6K | 0.44% | 63 |
|
|
2023
Q4 | $3.65M | Buy |
8,960
+132
| +1% | +$53.7K | 0.46% | 64 |
|
|
2023
Q3 | $3.07M | Buy |
8,828
+40
| +0.5% | +$13.9K | 0.44% | 66 |
|
|
2023
Q2 | $3.09M | Hold |
8,788
| – | – | 0.42% | 68 |
|
|
2023
Q1 | $2.77M | Sell |
8,788
-416
| -5% | -$131K | 0.39% | 70 |
|
|
2022
Q4 | $2.66M | Sell |
9,204
-363
| -4% | -$105K | 0.4% | 71 |
|
|
2022
Q3 | $2.77M | Sell |
9,567
-55
| -0.6% | -$15.9K | 0.46% | 65 |
|
|
2022
Q2 | $2.71M | Sell |
9,622
-8
| -0.1% | -$2.25K | 0.43% | 65 |
|
|
2022
Q1 | $2.51M | Buy |
9,630
+1,951
| +25% | +$509K | 0.33% | 76 |
|
|
2021
Q4 | $1.69M | Buy |
7,679
+805
| +12% | +$177K | 0.21% | 107 |
|
|
2021
Q3 | $1.25M | Hold |
6,874
| – | – | 0.16% | 127 |
|
|
2021
Q2 | $1.39M | Buy |
6,874
+1,480
| +27% | +$298K | 0.17% | 124 |
|
|
2021
Q1 | $1.16M | Buy |
5,394
+1,650
| +44% | +$355K | 0.15% | 129 |
|
|
2020
Q4 | $885K | Buy |
3,744
+129
| +4% | +$30.5K | 0.12% | 133 |
|
|
2020
Q3 | $984K | Sell |
3,615
-165
| -4% | -$44.9K | 0.15% | 117 |
|
|
2020
Q2 | $1.1M | Sell |
3,780
-30
| -0.8% | -$8.71K | 0.18% | 106 |
|
|
2020
Q1 | $907K | Buy |
+3,810
| New | +$907K | 0.17% | 105 |
|
|
2019
Q3 | – | Sell |
-613
| Closed | -$112K | – | 473 |
|
|
2019
Q2 | $112K | Buy |
+613
| New | +$112K | 0.01% | 291 |
|